Rani Therapeutics Holdings, Inc. cotiza a 0.75 USD y tiene una capitalización bursátil de $87M. En los últimos 12 meses ha facturado $5M con un margen de flujo de caja libre del -1151.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill cap…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.04 | $-0.07 | $-0.12 |
| Estimado | $-0.05 | $-0.04 | $-0.07 | $-0.12 |
| Sorpresa | — | +0.0% | +0.0% | +0.0% |
| Métrica | RANI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -2346.0% | -38.6% | -2307.4% |
| Net Margin | -1817.1% | -33.6% | -1783.5% |
| FCF Margin | -1151.4% | -13.9% | -1137.5% |
| ROE | -89.9% | -40.4% | -49.5% |
| ROA | -50.6% | -32.0% | -18.6% |
| Current Ratio | 4.21 | 2.84 | +1.37 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |